Skip to main content

and
  1. No Access

    Protocol

    The European Regulatory Environment of RNA-Based Vaccines

    A variety of different mRNA-based drugs are currently in development. This became possible, since major breakthroughs in RNA research during the last decades allowed impressive improvements of translation, sta...

    Thomas Hinz, Kajo Kallen, Cedrik M. Britten, Bruno Flamion, Ulrich Granzer in RNA Vaccines (2017)